331 related articles for article (PubMed ID: 8503554)
1. Comparison of the effects of salmeterol and formoterol on airway tone and responsiveness over 24 hours in bronchial asthma.
Rabe KF; Jörres R; Nowak D; Behr N; Magnussen H
Am Rev Respir Dis; 1993 Jun; 147(6 Pt 1):1436-41. PubMed ID: 8503554
[TBL] [Abstract][Full Text] [Related]
2. [Changes in specific airway resistance after powder inhalation of formoterol or salmeterol in moderate bronchial asthma].
Sill V; Bartuschka B; Villiger B; Ortland C; Domej W
Pneumologie; 1999 Jan; 53(1):4-9. PubMed ID: 10091511
[TBL] [Abstract][Full Text] [Related]
3. Comparison of the relative efficacy of formoterol and salmeterol in asthmatic patients.
Palmqvist M; Ibsen T; Mellén A; Lötvall J
Am J Respir Crit Care Med; 1999 Jul; 160(1):244-9. PubMed ID: 10390407
[TBL] [Abstract][Full Text] [Related]
4. Long-term effects of a long-acting beta 2-adrenoceptor agonist, salmeterol, on airway hyperresponsiveness in patients with mild asthma.
Cheung D; Timmers MC; Zwinderman AH; Bel EH; Dijkman JH; Sterk PJ
N Engl J Med; 1992 Oct; 327(17):1198-203. PubMed ID: 1357550
[TBL] [Abstract][Full Text] [Related]
5. In vivo effect of albuterol on methacholine-contracted bronchi in conjunction with salmeterol and formoterol.
Aziz I; Lipworth BJ
J Allergy Clin Immunol; 1999 May; 103(5 Pt 1):816-22. PubMed ID: 10329815
[TBL] [Abstract][Full Text] [Related]
6. Prevention of exercise-induced bronchospasm in pediatric asthma patients: a comparison of salmeterol powder with albuterol.
Blake K; Pearlman DS; Scott C; Wang Y; Stahl E; Arledge T
Ann Allergy Asthma Immunol; 1999 Feb; 82(2):205-11. PubMed ID: 10071526
[TBL] [Abstract][Full Text] [Related]
7. Diurnal change of bronchial caliber and airway responsiveness in asthmatics during long-term treatment with long-acting beta 2-agonist salmeterol.
Dottorini ML; Tantucci C; Peccini F; Grassi V; Sorbini CA
Int J Clin Pharmacol Ther; 1996 Oct; 34(10):438-43. PubMed ID: 8897082
[TBL] [Abstract][Full Text] [Related]
8. An inhaled glucocorticoid does not prevent tolerance to the bronchoprotective effect of a long-acting inhaled beta 2-agonist.
Yates DH; Kharitonov SA; Barnes PJ
Am J Respir Crit Care Med; 1996 Dec; 154(6 Pt 1):1603-7. PubMed ID: 8970342
[TBL] [Abstract][Full Text] [Related]
9. Comparison of salmeterol and albuterol-induced bronchoprotection against adenosine monophosphate and histamine in mild asthma.
Taylor DA; Jensen MW; Aikman SL; Harris JG; Barnes PJ; O'Connor BJ
Am J Respir Crit Care Med; 1997 Dec; 156(6):1731-7. PubMed ID: 9412548
[TBL] [Abstract][Full Text] [Related]
10. Prolonged protection against methacholine-induced bronchoconstriction by the inhaled beta 2-agonist formoterol.
Ramsdale EH; Otis J; Kline PA; Gontovnick LS; Hargreave FE; O'Byrne PM
Am Rev Respir Dis; 1991 May; 143(5 Pt 1):998-1001. PubMed ID: 1673830
[TBL] [Abstract][Full Text] [Related]
11. Formoterol, a new long-acting selective beta 2-agonist, decreases airway responsiveness in children with asthma.
Becker AB; Simons FE
Lung; 1990; 168 Suppl():99-102. PubMed ID: 1974689
[TBL] [Abstract][Full Text] [Related]
12. Bronchoprotection by salmeterol: cell stabilization or functional antagonism? Comparative effects on histamine- and AMP-induced bronchoconstriction.
Solèr M; Joos L; Bolliger CT; Elsasser S; Perruchoud AP
Eur Respir J; 1994 Nov; 7(11):1973-7. PubMed ID: 7875267
[TBL] [Abstract][Full Text] [Related]
13. The 24 h duration of bronchodilator action of the budesonide/formoterol combination inhaler.
Masoli M; Williams M; Weatherall M; Beasley R
Respir Med; 2006 Jan; 100(1):20-5. PubMed ID: 15936933
[TBL] [Abstract][Full Text] [Related]
14. The effect of inhaled salmeterol on methacholine responsiveness in subjects with asthma up to 12 hours.
Derom EY; Pauwels RA; Van der Straeten ME
J Allergy Clin Immunol; 1992 Apr; 89(4):811-5. PubMed ID: 1560164
[TBL] [Abstract][Full Text] [Related]
15. A single-dose comparison of inhaled albuterol and two formulations of salmeterol on airway reactivity in asthmatic subjects.
Gongora HC; Wisniewski AF; Tattersfield AE
Am Rev Respir Dis; 1991 Sep; 144(3 Pt 1):626-9. PubMed ID: 1679981
[TBL] [Abstract][Full Text] [Related]
16. Rebound airway obstruction and responsiveness after cessation of terbutaline: effects of budesonide.
de Jong JW; van der Mark TW; Koëter GH; Postma DS
Am J Respir Crit Care Med; 1996 Jan; 153(1):70-5. PubMed ID: 8542165
[TBL] [Abstract][Full Text] [Related]
17. Effect of regular salmeterol treatment on albuterol-induced bronchoprotection in mild asthma.
Yates DH; Worsdell M; Barnes PJ
Am J Respir Crit Care Med; 1997 Sep; 156(3 Pt 1):988-91. PubMed ID: 9310023
[TBL] [Abstract][Full Text] [Related]
18. Regular formoterol treatment in mild asthma. Effect on bronchial responsiveness during and after treatment.
Yates DH; Sussman HS; Shaw MJ; Barnes PJ; Chung KF
Am J Respir Crit Care Med; 1995 Oct; 152(4 Pt 1):1170-4. PubMed ID: 7551366
[TBL] [Abstract][Full Text] [Related]
19. Tolerance to bronchodilation during treatment with long-acting beta-agonists, a randomised controlled trial.
Haney S; Hancox RJ
Respir Res; 2005 Sep; 6(1):107. PubMed ID: 16168062
[TBL] [Abstract][Full Text] [Related]
20. Beta2-adrenoceptor regulation and bronchodilator sensitivity after regular treatment with formoterol in subjects with stable asthma.
Aziz I; Hall IP; McFarlane LC; Lipworth BJ
J Allergy Clin Immunol; 1998 Mar; 101(3):337-41. PubMed ID: 9525449
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
